Corium to Present at Upcoming Investor Conferences
MENLO PARK, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced …